Authors:
Raisch, DW
Klaurens, LM
Hayden, C
Malagon, I
Pulliam, G
Fass, R
Citation: Dw. Raisch et al., Impact of a formulary change in proton pump inhibitors on health care costs and patients' symptoms, DIG DIS SCI, 46(7), 2001, pp. 1533-1539
Authors:
Gerson, LB
Hatton, BN
Ryono, R
Jones, W
Pulliam, G
Sampliner, RE
Triadafilopoulos, G
Fass, R
Citation: Lb. Gerson et al., Clinical and fiscal impact of lansoprazole intolerance in veterans with gastro-oesophageal reflux disease, ALIM PHARM, 14(4), 2000, pp. 397-406
Authors:
Fass, R
Murthy, U
Hayden, CW
Malagon, IB
Pulliam, G
Wendel, C
Kovacs, TOG
Citation: R. Fass et al., Omeprazole 40 mg once a day is equally effective as lansoprazole 30 mg twice a day in symptom control of patients with gastro-oesophageal reflux disease (GERD) who are resistant to conventional-dose lansoprazole therapy - a prospective, randomized, multi-centre study, ALIM PHARM, 14(12), 2000, pp. 1595-1603
Authors:
Fass, R
Pulliam, G
Johnson, C
Garewal, HS
Sampliner, RE
Citation: R. Fass et al., Symptom severity and oesophageal chemosensitivity to acid in older and young patients with gastro-oesophageal reflux, AGE AGEING, 29(2), 2000, pp. 125-130
Authors:
Colon, V
Grade, A
Pulliam, G
Johnson, C
Fass, R
Citation: V. Colon et al., Effect of doses of glucagon used to treat food impaction on esophageal motor function of normal subjects, DYSPHAGIA, 14(1), 1999, pp. 27-30
Authors:
Fass, R
Hell, R
Sampliner, RE
Pulliam, G
Graver, E
Hartz, V
Johnson, C
Jaffe, P
Citation: R. Fass et al., Effect of ambulatory 24-hour esophageal pH monitoring on reflux-provoking activities, DIG DIS SCI, 44(11), 1999, pp. 2263-2269